Showing results (1-10 of 650) with videos related to
Sort By:
Pageof 65
Clinical Chemistry and Laboratory Medicine|February 7, 2014
Cardiac biomarkers and risk assessment in patients undergoing major non-cardiac surgery: time to revise the guidelines?Aldo Clerico, Michele Emdin, Claudio PassinoClinical Chemistry and Laboratory Medicine|November 24, 2004
The significance of serum gamma-glutamyltransferase in cardiovascular diseasesAlfonso Pompella, Michele Emdin, Claudio Passino, et al.European Journal of Heart Failure|March 31, 2009
Old and new biomarkers of heart failureMichele Emdin, Simona Vittorini, Claudio Passino, et al.Future Cardiology|July 28, 2016
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectivesAldo Clerico, Claudio Passino, Maria Franzini, et al.Recenti Progressi in Medicina|July 15, 2006
[The prognostic role of gamma-glutamyltransferase for cardiovascular events]Michele Emdin, Alfonso Pompella, Claudio Passino, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|June 18, 2014
Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptidesAldo Clerico, Claudio Passino, Maria Franzini, et al.Giornale Italiano Di Cardiologia (2006)|December 17, 2013
[Biomarkers in heart failure: an update]Michele Emdin, Andrea Barison, Claudio Passino, et al.Critical Reviews in Clinical Laboratory Sciences|June 12, 2009
New and emerging biomarkers of heart failureAldo Clerico, Simona Vittorini, Claudio Passino, et al.American Journal of Physiology. Heart and Circulatory Physiology|December 24, 2005
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implicationsAldo Clerico, Fabio A Recchia, Claudio Passino, et al.Pharmacological Research|August 15, 2006
C-type natriuretic peptide and heart failureSilvia Del Ry, Claudio Passino, Michele Emdin, et al.Pageof 65